3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Prostatic Neoplasms
3
Leukemia
3
Hematologic Neoplasms
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Lymphoma, B-Cell
2
Lung Neoplasms
2
Carcinoma in Situ
2
Burkitt Lymphoma
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Peritoneal Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Nose Neoplasms
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Interventions
selpercatinib
2
pralsetinib
2
pembrolizumab
2
Pemetrexed
2
Paclitaxel
2
Carboplatin
2
patritumab
1
osimertinib
1
napabucasin
1
efineptakin alfa
1
durvalumab
1
cobimetinib
1
atezolizumab
1
alectinib
1
Tyrosine Kinase Inhibitors
1
Radiosurgery
1
Proton Therapy
1
Metformin
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Dasatinib
1
Cisplatin
1
Bevacizumab
1
Afatinib
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thoracic Neoplasms
×
Electrocardiography
×
Clear all
No trials found.